Ironwood Pharmaceuticals, Inc. (IRWD)

NMS – Real Time Price. Currency in USD

4.41

+0.12 (2.67%)

Market open: Aug 12, 2026, 3:35 PM EDT

4.31

+0.01 (0.23%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

296M

351M

443M

411M

Cost of goods sold

-2M

-1M

Gross Profit

294M

349M

441M

409M

Operating expenses (excl. COGS)

-176M

-254M

-232M

-159M

Operating Income

119M

96M

209M

250M

Non-operating income, total

-49M

-31M

-1.16B

Pretax income

70M

65M

-948M

252M

Equity in earnings

Taxes

-46M

-64M

-83M

-77M

Non-controlling/minority interest

29M

After tax other income/expense

Net income before discontinued operations

24M

880K

-1B

175M

Discontinued operations

Net income

24M

880K

-1B

175M

Dilution adjustment

Preferred dividends

Ironwood Pharmaceuticals, Inc. (IRWD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ironwood Pharmaceuticals, Inc. (IRWD)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Ironwood Pharmaceuticals, Inc. (IRWD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ironwood Pharmaceuticals, Inc. (IRWD)

Income Statement (Annual)

Income Statement (Annual)